Editing Healthcare System (The Netherlands)

<span style="display:none">forpatients</span>
<span style="display:none">forpolicymakers</span>
<span style="display:none">forresearchers</span>
<span style="display:none">forproviders</span>
<span style="display:none">thenetherlandscountry</span>
Go back to [[The Netherlands]] page

The Netherlands employs a three-tiered system of healthcare funding: 1) a social insurance system for curative care operated by competing private insurers; 2) a single-payer social insurance for long-term care; 3) a tax-funded social care system implemented by municipalities. This structure ensures broad universal healthcare coverage for all residents.

The Ministry of Health, Welfare, and Sport oversees the system. The Dutch Healthcare Authority regulates and sets healthcare prices. Health Insurance Board manages health insurance funds. Local authorities play a key role in the social care system, aiding in public health and social support.

Residents have broad access to healthcare benefits, including GP services, medical specialists, hospital care, mental healthcare, maternity care, pharmaceuticals, medical aids, and some allied care services. The social care system supports housekeeping, help with daily activities, and sheltered living, and long-term care insurance covers intensive, continuous care.

All residents and workers in the Netherlands must have standard health insurance. Insurance companies must accept every resident in their coverage area. The Netherlands operates a strict gatekeeper system; a referral from a GP is necessary for hospital and specialist care. Premiums are income-dependent, with allowances for low-income groups.

The Netherlands boasts a comprehensive digital healthcare infrastructure. EHR systems are widely used among GPs, pharmacists, hospitals, and other healthcare providers. The national exchange point (Landelijk Schakelpunt or LSP) allows secure exchange of medical data among healthcare providers. Specific registries exist for certain diseases and interventions, ensuring high-quality data for monitoring, research, and quality improvement.
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
<span style="display:none">hasCancerType::C00-C97: All cancer types</span>
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
<span style="display:none">hasCancerType::C50: Breast cancer</span>
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
<span style="display:none">hasCancerType::unknown</span>